Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
This trial is active, not recruiting.
|Condition||human immunodeficiency virus|
|Sponsor||Johns Hopkins University|
|Collaborator||National Institutes of Health (NIH)|
|Start date||January 2005|
|Trial size||101 participants|
|Trial identifier||NCT00244803, 03-07-02-01|
The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.
|Observational model||defined population|
Male or female participants from 18 years up to 65 years old.
Inclusion Criteria:18-65 years old, previous FRAM 1 participant, HIV positive - Exclusion Criteria:Artificial knee or hip replacement or Harrington rod.Metal objects in the body.Pregnancy. Breastfeeding or less than 3 months after breastfeeding.Weight more than 300 pounds.On insulin, pancreatic enzymes, or thioridazine. -
|Official title||Redistribution and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)|
|Principal investigator||Joseph Cofrancesco Jr., M.D.|
|Description||This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distributed in their body and in how their body handles fat and sugars. If there are abnormalities, this study will also try to find out what factors may contribute to those abnormalitites. People who participated in FRAM 1 may join FRAM 2.|
Call for more information